View : 91 Download: 1

Full metadata record

DC Field Value Language
dc.contributor.author임경민-
dc.date.accessioned2019-02-26T16:30:01Z-
dc.date.available2019-02-26T16:30:01Z-
dc.date.issued2019-
dc.identifier.issn1743-8977-
dc.identifier.otherOAK-24431-
dc.identifier.urihttp://dspace.ewha.ac.kr/handle/2015.oak/249371-
dc.description.abstractSilver nanoparticles (AgNP) are widely used in medical practices owing to their distinct antibacterial, antiviral and anticancer activities. However, with increasing use of AgNP, concerns over its potential toxicity are also escalating. Here, we demonstrated the potential thrombotic effect of AgNP which was mediated by the procoagulant activity of red blood cells (RBCs). In freshly isolated human RBCs, AgNP, but not silver microparticles (AgMP), elicited morphological changes, phosphatidylserine (PS) exposure and microvesicles (MV) generation, the key indicators of procoagulant activity in RBCs at concentration ranges (ae<currency> 100 mu g/mL) that were free of significant hemolysis. In line with this, AgNP potentiated thrombin generation and adherence of RBCs to endothelial cells, while AgMP did not. Oxidative stress, intracellular calcium increase and ATP depletion were found to underlie the procoagulant effects of AgNP, which led to altered activity of membrane aminophospholipid translocases. These in vitro findings were well reproduced in rat in vivo, where intravenously exposure to AgNP promoted venous thrombosis significantly. Of note, RBCs isolated from cancer patients, who inherently convey the risk of thrombogenesis, were more sensitive to the procoagulant effects of AgNP. In addition, AgNP significantly potentiated the procoagulant effects of a chemotherapeutic drug, paclitaxel. Collectively, these results suggest that AgNP may have prothrombotic risks by promoting procoagulant activity of RBCs and caution shall be taken for its use in the population sensitive to thrombosis like cancer patients.-
dc.languageEnglish-
dc.publisherBMC-
dc.subjectSilver nanoparticles (AgNP)-
dc.subjectToxicity-
dc.subjectThrombosis-
dc.subjectRed blood cells (RBCs)-
dc.subjectCancer-
dc.titleSilver nanoparticles promote procoagulant activity of red blood cells: a potential risk of thrombosis in susceptible population-
dc.typeArticle-
dc.relation.volume16-
dc.relation.indexSCI-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.journaltitlePARTICLE AND FIBRE TOXICOLOGY-
dc.identifier.doi10.1186/s12989-019-0292-6-
dc.identifier.wosidWOS:000459183000001-
dc.identifier.scopusid2-s2.0-85061555851-
dc.author.googleBian, Yiying-
dc.author.googleKim, Keunyoung-
dc.author.googleThien Ngo-
dc.author.googleKim, Inho-
dc.author.googleBae, Ok-Nam-
dc.author.googleLim, Kyung-Min-
dc.author.googleChung, Jin-Ho-
dc.contributor.scopusid임경민(8916551700)-
dc.date.modifydate20190729144243-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE